BENDER ROBERT & ASSOCIATES
Q2 2014 13F-HR Holdings
Net value change ($000)
-7,766
(-5.2%)
New positions
3
Sold out positions
2
Turnover %
8.3%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2014
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| AAPL | 14,772 | 1767.0% |
| ALPHABET INC CL C | 3,487 | NEW |
| PHARMACYCLICS INC | 2,071 | 430.6% |
| BIDU | 1,896 | 348.5% |
| ILMN | 1,764 | 17.3% |
| CELG | 1,550 | 21.4% |
| GILD | 1,312 | 16.9% |
| VIPS | 905 | 26.8% |
| Cavium | 497 | 12.1% |
| MEDIVATION | 418 | 25.6% |
Top Reduces (Value $000, Stocks/ETFs)
| BMY | -22,039 | -97.8% |
| Zalemark Holding Company, Inc. | -7,713 | -100.0% |
| Alphabet Inc. Class C | -3,286 | -47.8% |
| LULU | -1,279 | -23.5% |
| VMWA | -719 | -11.2% |
| ISRG | -462 | -6.5% |
| POWI | -419 | -15.6% |
| CTSH | -323 | -4.1% |
| ARCO | -277 | -23.1% |
| WOLF | -270 | -12.5% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|